December 1, 2025 · Form 4 insider transaction
BELANOFF JOSEPH K sold 40,000 shares of Corcept Therapeutics Incorporated at $79.77 per share, a transaction worth $3.19M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.; Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.65 to $79.97 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.; Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.